Dermata Therapeutics (DRMA) Change in Cash (2020 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Change in Cash of -$576696.0 for Q1 2026, down 108.79% year-over-year from $6.6 million in Q1 2025, and down 120.18% quarter-over-quarter from $2.9 million in Q4 2025.
Dermata Therapeutics (DRMA) Change in Cash (2020 - 2026) Analysis & Trends
Dermata Therapeutics' Change in Cash history runs 7 years deep, the most recent figure standing at -$576696.0 for Q1 2026.
- In Q1 2026, Change in Cash fell 108.79% year-over-year to -$576696.0; the TTM figure through Mar 2026 stood at -$2.8 million (down 155.64% YoY), while the FY2025 annual figure was $4.4 million, up 201.96% from the prior year.
- Change in Cash for Q1 2026 stood at -$576696.0, down from $2.9 million in the prior quarter.
- The five-year high for Change in Cash was $6.6 million in Q1 2025, with the low at -$3.2 million in Q2 2025.
- The 5-year median for Change in Cash is -$576696.0 (2026), against an average of -$226677.9.
- The sharpest annual moves came in 2022 and 2025: Change in Cash jumped 369.81% in 2022, then plunged 1617.36% in 2025.
- Dermata Therapeutics' Change in Cash stood at -$1.8 million in 2022, then surged by 144.19% to $806652.0 in 2023, then sank by 469.7% to -$3.0 million in 2024, then jumped by 195.83% to $2.9 million in 2025, then plunged by 120.18% to -$576696.0 in 2026.
- Business Quant data shows DRMA's Change in Cash at -$576696.0 in Q1 2026, $2.9 million in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Dermata Therapeutics | 5.40 Mn | 5.40 Mn | - | -576,696.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -576,696.00 |
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -3.24 Mn |
| Mar 31, 2025 | 6.56 Mn |
| Dec 31, 2024 | -2.98 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 213,419.00 |
| Mar 31, 2024 | -2.70 Mn |
| Dec 31, 2023 | 806,652.00 |
| Sep 30, 2023 | -1.81 Mn |
| Jun 30, 2023 | -328,229.00 |
| Mar 31, 2023 | 2.53 Mn |
| Dec 31, 2022 | -1.83 Mn |
| Sep 30, 2022 | -2.56 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | -2.61 Mn |
| Dec 31, 2021 | -1.80 Mn |
| Sep 30, 2021 | 12.18 Mn |
| Jun 30, 2021 | -903,213.00 |